Open App →
Back to News Feed
Wired November 5, 2026 By Joel Khalili neutral

Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work

AI / LLMSemiconductors
Potential Sciences, a startup backed by the UK government, is betting that training AI models on computer-generated biochemical data can speed up the plodding process of developing new drugs.
Read original article ↗

Related Articles

Pipit Launches Music Platform Where "The Fan Becomes the Algorithm"

Built exclusively for human independent artists, Pipit introduces customizable subscription models and direct-to-artist

PR Newswire · November 5, 2026

The Freedonia Group Launches New Website, Emphasizing Key Analysts in an AI-Driven Research Market

New site unifies Freedonia's four research brands and gives customers direct access to accountable, US-based analysts. R

PR Newswire · November 5, 2026

Z Squared Advances Debt-Free Arkansas AI Campus as Build-Out Bottlenecks Constrain Major Markets

Z Squared Inc. capitalizes on zero legacy debt to scale a 100 MW digital infrastructure footprint while tight credit mar

PR Newswire · November 5, 2026

Cellebrite Appoints Rogerio Rizzi Executive Vice President of Corporate Strategy and Development

Former Okta and SAP strategy leader brings AI, platform and M&A expertise to accelerate Cellebrite's growth TYSONS CORNE

PR Newswire · November 5, 2026